Reta 60mg

Description

Research Use Only Reta is intended strictly for laboratory research and in-vitro or other non-clinical research applications. It is not intended for human or veterinary use, consumption, diagnosis, treatment, prevention, or mitigation of any disease or medical condition and has not been evaluated or approved as a medicine or dietary supplement. Reta is a laboratory research peptide investigated for its activity across three key metabolic signalling pathways: GLP-1, GIP, and the glucagon receptor. This class of research compound is studied in non-clinical laboratory models exploring incretin signalling, metabolic pathways, glucose-response mechanisms, energy-balance processes, and receptor interactions. GLP-1 is widely investigated for its involvement in incretin signalling and glucose-response pathways. GIP is studied in relation to nutrient-responsive signalling and metabolic regulation, while glucagon receptor activity is examined in research involving energy utilisation, hepatic signalling, and broader metabolic pathway function. The combined activity of these three receptor pathways makes Reta relevant to laboratory research focused on multi-receptor peptide activity and metabolic signalling within controlled, non-clinical research environments.